Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D. Michael Clayman

Affiliations

  • President And Ceo at Flexion Therapeutics Inc (FLXN), 2019-08-08
  • at Akebia Therapeutics Inc. (AKBA), 2018-06-15
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FLXN $10.85 2,317 Officer, Director 72,249 2019-08-08 Filing
FLXN $12.48 4,012 Officer, Director 74,868 2019-05-10 Filing
FLXN $12.36 4,046 Officer, Director 70,856 2019-03-12 Filing
FLXN $17.10 5,000 Officer, Director 69,166 2018-11-09 Filing
FLXN $22.33 10,000 Officer, Director 75,282 2018-08-09 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FLXN $12.36 3,278 Officer, Director 66,810 2019-01-03 Filing